A Comprehensive Review on Electrochemical Nano Biosensors for Precise Detection of Blood-Based Oncomarkers in Breast Cancer.
Mahdi SadeghiSomayeh SadeghiSeyed Morteza NaghibHamid Reza GarshasbiPublished in: Biosensors (2023)
Breast cancer (BC), one of the most common and life-threatening cancers, has the highest incidence rate among women. Early diagnosis of BC oncomarkers is considered the most effective strategy for detecting and treating BC. Finding the type and stage of BC in women as soon as possible is one of the greatest ways to stop its incidence and negative effects on medical treatment. The development of biosensors for early, sensitive, and selective detection of oncomarkers has recently attracted much attention. An electrochemical nano biosensor (EN) is a very suitable option for a powerful tool for cancer diagnosis. This comprehensive review provides information about the prevalence and pathobiology of BC, recent advances in clinically available BC oncomarkers, and the most common electrochemical nano biosensors for point-of-care (POC) detection of various BC oncomarkers using nanomaterial-based signal amplification techniques.
Keyphrases
- label free
- gold nanoparticles
- risk factors
- healthcare
- polycystic ovary syndrome
- loop mediated isothermal amplification
- ionic liquid
- breast cancer risk
- molecularly imprinted
- pregnant women
- type diabetes
- papillary thyroid
- insulin resistance
- mass spectrometry
- combination therapy
- childhood cancer
- health information
- replacement therapy
- working memory
- young adults
- skeletal muscle
- liquid chromatography
- nucleic acid
- simultaneous determination